◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
智飞生物 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
+Revenue 26.1B 52.9B 38.3B 30.7B 15.2B
Revenue Growth % -50.7% 38.3% 24.8% 101.8% --
Total Revenue 26.1B 52.9B 38.3B 30.7B 15.2B
Cost Of Revenue 18.9B 38.7B 25.4B 15.6B 9.3B
+Gross Profit 7.1B 14.2B 12.9B 15.0B 5.9B
Gross Margin % 27.4% 26.9% 33.6% 49.0% 39.0%
Total Operating Cost 23.8B 43.8B 29.6B 18.8B 11.3B
Selling Expenses 2.7B 2.8B 2.2B 1.8B 1.2B
Admin Expenses 394.0M 393.0M 374.0M 300.0M 212.0M
Rd Expenses 971.0M 968.0M 854.0M 553.0M 300.0M
Finance Expenses 109.0M 47.2M 13.8M 21.8M 131.0M
+Operating Income 2.3B 9.4B 8.8B 12.0B 3.9B
Operating Margin % 8.7% 17.7% 22.9% 39.1% 25.6%
Non Operating Income 69,500 337,700 611,800 185,000 130,500
Non Operating Expenses 10.2M 31.5M 41.0M 69.1M 41.1M
Investment Income -- -- -- -20.0M 751,800
Fair Value Change Income -- -- -- 14.4M -13.3M
Asset Disposal Income 46,900 41.4M 6,700 39,100 -4,600
Asset Impairment Loss 39.5M 312.0M 109.0M 92.5M 47.8M
Other Income 41.8M 173.0M 74.6M 103.0M 28.1M
Income Before Tax 2.3B 9.3B 8.7B 11.9B 3.9B
Income Tax 235.0M 1.3B 1.2B 1.7B 553.0M
+Net Income 2.0B 8.1B 7.5B 10.2B 3.3B
Net Margin % 7.7% 15.3% 19.7% 33.3% 21.7%
Net Income Attributable 2.0B 8.1B 7.5B 10.2B 3.3B
Eps Basic 0.84 3.36 3.14 6.38 2.06
Eps Diluted 0.84 3.36 3.14 6.38 2.06
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash And Equivalents 2.7B 6.3B 2.6B 4.3B 1.4B
Trading Financial Assets 11.5M -- -- -- --
Accounts Receivable 16.3B 27.1B 20.6B 12.9B 6.6B
Notes Receivable -- -- -- -- --
Notes And Accounts Receivable 16.3B 27.1B 20.6B 12.9B 6.6B
Prepayments 50.4M 74.4M 103.0M 186.0M 55.7M
Inventory 22.2B 9.0B 8.0B 7.4B 3.4B
Total Current Assets 41.4B 42.5B 31.4B 24.8B 11.5B
Long Term Equity Investment -- -- -- -- --
Fixed Assets -- 3.8B 2.8B 1.7B 1.5B
Fixed Assets Total 4.6B 3.8B 2.8B 1.7B 1.5B
Construction In Progress -- 1.3B 1.8B 1.8B 906.0M
Construction In Progress Total 1.6B 1.3B 1.8B 1.8B 906.0M
Intangible Assets 346.0M 318.0M 353.0M 343.0M 271.0M
Long Term Deferred Expenses 97.0M 83.0M 28.2M 40.5M 37.5M
Total Non Current Assets 9.9B 7.7B 6.6B 5.3B 3.7B
Total Assets 51.3B 50.2B 38.0B 30.0B 15.2B
Short Term Borrowings 11.9B 2.6B 1.8B 569.0M 2.9B
Accounts Payable 5.5B 13.1B 9.8B 9.2B 3.0B
Advance Receipts 23.9M 114.0M 9.1M 70.9M 445,300
Contract Liabilities 11.9M 11.3M -- -- --
Total Current Liabilities 18.9B 18.1B 13.2B 11.9B 6.8B
Long Term Borrowings 1.2B 328.0M 211.0M 236.0M --
Total Non Current Liabilities 1.6B 640.0M 538.0M 519.0M 150.0M
Total Liabilities 20.4B 18.7B 13.8B 12.4B 7.0B
Paid In Capital 2.4B 2.4B 1.6B 1.6B 1.6B
Capital Reserve 198.0M 48.0M 208.0M 208.0M 208.0M
Surplus Reserve 1.2B 1.2B 800.0M 800.0M 785.0M
Retained Earnings 27.0B 27.9B 21.6B 15.0B 5.7B
Minority Equity -2.2M -- -- -- --
Equity Attributable 30.8B 31.5B 24.2B 17.7B 8.2B
Total Equity 30.8B 31.5B 24.2B 17.7B 8.2B
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash From Sales 36.9B 47.8B 31.2B 25.2B 13.4B
Tax Refunds Received -- -- 630,600 -- --
Total Operating Cash Inflow 37.1B 48.1B 31.4B 25.5B 13.5B
Cash Paid For Goods 35.5B 31.9B 22.9B 12.2B 7.4B
Cash Paid To Employees 1.8B 1.5B 1.3B 1.0B 671.0M
Taxes Paid 2.1B 3.3B 3.3B 2.0B 875.0M
Total Operating Cash Outflow 41.5B 39.1B 29.4B 17.0B 10.0B
Operating Cash Flow -4.4B 9.0B 2.0B 8.5B 3.5B
Total Investing Cash Inflow 4.8M 168.0M 646,800 502.0M 101,100
Total Investing Cash Outflow 930.0M 1.1B 1.5B 2.5B 897.0M
Investing Cash Flow -926.0M -977.0M -1.5B -2.0B -897.0M
Cash From Borrowings 14.7B 6.3B 5.5B 2.6B 6.7B
Dividends And Interest Paid 2.5B 889.0M 1.0B 862.0M 929.0M
Debt Repayments 10.2B 9.7B 6.6B 5.3B 8.0B
Total Financing Cash Inflow 14.7B 6.3B 5.5B 2.7B 7.4B
Total Financing Cash Outflow 13.0B 10.6B 7.7B 6.3B 9.5B
Financing Cash Flow 1.7B -4.3B -2.2B -3.6B -2.1B
Net Change In Cash -3.6B 3.7B -1.7B 2.9B 481.0M
Ending Cash Balance 2.7B 6.3B 2.6B 4.3B 1.4B
Capex 930.0M 1.1B 1.5B 1.9B 827.0M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...